Loading organizations...
Loading organizations...
Biopharmaceutical company developing innovative cancer treatments.
Phrontline Biopharma has raised $73.7M across 2 funding rounds.
Phrontline Biopharma has raised $73.7M in total across 2 funding rounds.
Phrontline Biopharma has raised $73.7M in total across 2 funding rounds.
Phrontline Biopharma's investors include 王及, Decheng Capital, Med-Fine Capital, Samsung, Sino Biopharmaceutical.
Phrontline Biopharma has raised $73.7M across 2 funding rounds. Most recently, it raised $60.0M Pre-Series A in November 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 25, 2025 | $60.0M Pre-Series A | 王及 | Decheng Capital, Med-Fine Capital, Samsung, Sino Biopharmaceutical |
| Jun 27, 2024 | $13.7M Pre-Series A | Decheng Capital |